• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
AVCJ
  • Buyouts

Alibaba, OTPP join founder-led consortium bidding for iKang

  • Tim Burroughs
  • 06 January 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  

Alibaba Group and Ontario Teachers’ Pension Plan (OTPP) have joined a consortium led by the founder and CEO of iKang Healthcare Group that is involved in a competitive battle to privatize the US-listed company.

Ligang Zhang initially teamed up with FountainVest Partners last August to submit a bid of $17.80 per share for all outstanding American Depository Shares. The price represented a 10.8% premium to the previous close and valued iKang - which had listed just four months earlier - at around $1.2 billion.

The terms are unaltered in the latest filing, but the consortium has expanded to include China Life, Legend Capital, New China Capital International and LTW Capital Jaguar Investment as well as Alibaba and OTPP.

The move follows the submission of a rival bid from a consortium that features Meinian Onehealth, a direct competitor to iKang. That consortium, which also includes Sequoia Capital, Cathay Capital Private Equity, Shenzhen Ping An Decheng Investment, Taiping Guofa Capital and Huatai Ruilian Fund Management, offered $22.00 per share.

The management of iKang responded by announcing a rights issue, or "poison pill" strategy, to thwart the Meinian bid. The consortium countered with an improved offer of $23.50 per share.

Set up in 2004, Beijing-based iKang provides medical examination services through 80 self-owned medical centers in 22 cities, as of November 2015. Outpatient services and dental treatment are also provided by a minority of these centers. Third-party service providers are used in 150 cities.

As of June 2015, Zhang held a 12.95% stake in iKang, while Boquan He, the company's vice chairman, had 13.23%. GIC Private owned 5.96%. However, Zhang has 34.5% of the total voting power.

IKang raised $153 million in a US IPO in April last year, allowing NewQuest Capital Partners and GIC to make partial exits. Goldman Sachs, another PE backer, didn't sell any shares in the offering, while an investment vehicle controlled by China Investment Corporation (CIC), bought $40 million worth of shares, representing a 4.6% stake.

The company reported revenue of $290.7 million in 2015, up from $202.3 million the previous year. It also generated a net profit of $26.8 million compared to losses of $6.1 million and $75 million in 2014 and 2013.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Save this article  
  • Send to  
  • Topics
  • Buyouts
  • Healthcare
  • Greater China
  • healthcare
  • China
  • buyout
  • Fountainvest Partners
  • Alibaba Group
  • OTPP
  • China Life
  • Legend Capital

More on Buyouts

hkma-yichen-zhang
Lower valuations, less leverage could drive China PE returns - HKMA Forum
  • Greater China
  • 09 Nov 2023
power-grid-electricity-energy
Energy transition: Getting comfortable
  • Australasia
  • 08 Nov 2023
jean-eric-salata-baring-2019
Q&A: BPEA EQT’s Jean Eric Salata
  • GPs
  • 08 Nov 2023
gas-refining-plant
Ascendent bids $1.6b for China's Hollysys Automation
  • Greater China
  • 07 Nov 2023

Latest News

world-hands-globe-climate-esg
Asian GPs slow implementation of ESG policies - survey

Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...

  • GPs
  • 10 November 2023
housing-house-home-mortgage
Singapore fintech start-up LXA gets $10m seed round

New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.

  • Southeast Asia
  • 10 November 2023
india-rupee-money-nbfc
India's InCred announces $60m round, claims unicorn status

Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”

  • South Asia
  • 10 November 2023
roller-mark-luke-finn
Insight leads $50m round for Australia's Roller

Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.

  • Australasia
  • 10 November 2023
Back to Top
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013